CARLSBAD, Calif. & HAYWARD, Calif. & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--June 13, 2006--Invitrogen Corporation (Nasdaq:IVGN - News), a provider of essential life science technologies for disease research and drug discovery, and Solexa, Inc. (Nasdaq:SLXA - News), a provider of next-generation genetic analysis systems, today announced a collaboration through which Invitrogen will supply many of the reagents for Solexa’s sequencing, gene expression, and small RNA analysis kits designed to be used with the Solexa Genome Analysis System. Financial terms of the collaboration were not disclosed.
